Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : AMERICAN BIOMED, Minimally Invasive Technology (ABMI) -- Ignore unavailable to you. Want to Upgrade?

To: R.C.L. who wrote (205)	3/18/1998 12:09:00 AM
From: Jeffrey L. Henken	Respond to of 2887

LATEX AND LAWSUITS! Great posts Bob! There is nothing more motivating than a big jury award in a lawsuit against a hospital and or a physician to make some needed changes in their medical practices. Latex allergies can and do kill people. More lawsuits will arise. Ultimately this means big sales for ABMI. Only American BioMed has an all silicone catheter line! I spoke with Dr Ahn tonight on this subject and will go into further details soon. Go ABMI, Regards, Jeff

To: R.C.L. who wrote (205)	3/21/1998 3:05:00 PM
From: Jeffrey L. Henken	Respond to of 2887

American BioMed is awaiting FDA approval of four variations of their bi-lumen catheters. It could happen any day now: In August 1997, American BioMed submitted a 510(k) to the U.S. Food and Drug Administration (FDA) for marketing approval of its 100% silicone-based bi-lumen balloon infusion catheters for thrombectomy and thrombolysis. The application includes four variations of the bi-lumen catheter presently being marketed, each differentiated by the placement of balloons on the catheter. Go ABMI! Regards, Jeff